ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹3,528 Cr | ₹3,220 Cr | ₹2,834 Cr | ₹2,221 Cr | ₹1,726 Cr |
What is the latest Total Liabilities ratio of ALIVUS LIFE SCIENCES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹3,528 Cr |
Mar2023 | ₹3,220 Cr |
Mar2022 | ₹2,834 Cr |
Mar2021 | ₹2,221 Cr |
Mar2020 | ₹1,726 Cr |
How is Total Liabilities of ALIVUS LIFE SCIENCES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3,528 Cr | 9.55 | |
Mar2023 | ₹3,220 Cr | 13.65 | |
Mar2022 | ₹2,834 Cr | 27.62 | |
Mar2021 | ₹2,221 Cr | 28.68 | |
Mar2020 | ₹1,726 Cr | - |
Compare Total Liabilities of peers of ALIVUS LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALIVUS LIFE SCIENCES | ₹12,947.2 Cr | 0.1% | 5.6% | 24.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
ALIVUS LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALIVUS LIFE SCIENCES | 0.1% |
5.6% |
24.4% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses